KOSDAQ
Every company in the roster listed on KOSDAQ.
Every company in the roster listed on KOSDAQ.
30 of 30 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Ahn-Gook Pharmaceutical001540 · KOSDAQ | 2 assets: 2 Ph 3 | AG2304Phase 3 · Atherosclerotic Cardiovascular DiseasePartial signal | None on record | — | — | — | ~$14M |
Alteogen Inc.196170 · KOSDAQ | 1 asset: 1 other | Aflibercept (Eyluxvi)Age-Related Macular Degeneration | None on record | — | — | — | — |
Anterogen065660 · KOSDAQ | 1 asset: 1 Ph 2 | ALLO-ASCPhase 2 · Dystrophic Epidermolysis BullosaWeak signal | None on record | — | — | — | — |
AprilBio397030 · KOSDAQ | 1 asset: 1 Ph 2 | EVO301Phase 2 · Atopic DermatitisPartial signal | None on record | — | — | — | — |
Aptabio Therapeutics293780 · KOSDAQ | 1 asset: 1 Ph 2 | IsuzinaxibPhase 2 · Type 2 DiabetesPartial signal | 30 Jun 2027Isuzinaxib · Phase 2 | — | — | — | — |
CJ Bioscience, Inc.311690 · KOSDAQ | 1 asset: 1 Ph 2 | CJRB-101Phase 1/2 · Non-Small Cell Lung Cancer | None on record | — | — | — | — |
Curacle365270 · KOSDAQ | 2 assets: 2 Ph 2 | CU01-1001Phase 2 · Chronic Kidney DiseasePartial signal | None on record | — | — | — | — |
D&D Pharmatech347850 · KOSDAQ | 1 asset: 1 Ph 2 | ZabopegdutidePhase 2 · ObesityPartial signal | None on record | — | — | — | — |
Enzychem Lifesciences183490 · KOSDAQ | 1 asset: 1 Ph 2 | MosedipimodPhase 2 · Atopic Dermatitis | Oct 2027Mosedipimod · Phase 2 | — | — | — | — |
GemVax & KAEL082270 · KOSDAQ | 1 asset: 1 Ph 3 | TertomotidePhase 3 · Alzheimer's DiseasePartial signal | None on record | — | $15MMar 2026 | ~7.6 qtrs | ~$5.6M |
GI Innovation, Inc.358570 · KOSDAQ | 3 assets: 3 Ph 2 | Efdelikofusp alfaPhase 1/2 · Non-Small Cell Lung Cancer | Feb 2027GI-108 · Phase 1/2 | — | — | — | — |
HK inno.N Corporation195940 · KOSDAQ | 4 assets: 3 Ph 3, 1 Ph 2 | Amlodipine/valsartan/atorvastatin (CJ-30061)Phase 3 · Atherosclerotic Cardiovascular DiseasePartial signal | None on record | — | — | — | — |
HLB Life Science067630 · KOSDAQ | 2 assets: 2 Ph 3 | ApatinibPhase 3 · Non-Small Cell Lung CancerReliable signal | Nov 2026Pyrotinib · Phase 1/2 | — | — | — | — |
Huons084110 · KOSDAQ | 1 asset: 1 Ph 1 | Liraglutide (HUC2-676)Phase 1 · Obesity | None on record | — | $134MDec 2025 | — | $47M |
IntoCell, Inc287840 · KOSDAQ | 1 asset: 1 Ph 1 | ITC-6146ROPhase 1 · Non-Small Cell Lung Cancer | 30 Jun 2027ITC-6146RO · Phase 1 | — | — | — | — |
Kainos Medicine284620 · KOSDAQ | 2 assets: 1 Ph 2, 1 Ph 1 | KM-819Phase 2 · Parkinson's DiseasePartial signal | None on record | — | — | — | — |
Kangstem Biotech217730 · KOSDAQ | 1 asset: 1 Ph 2 | Furestem-CDPhase 1/2 · Crohn's DiseaseWeak signal | None on record | — | — | — | — |
LigaChem Biosciences, Inc.141080 · KOSDAQ | 2 assets: 1 Ph 2, 1 Ph 1 | LCB84Phase 1/2 · Non-Small Cell Lung Cancer | Jan 2027LCB84 · Phase 1/2 | — | — | — | — |
Mezzion Pharma140410 · KOSDAQ | 1 asset: 1 Ph 3 | UdenafilPhase 2/3 · Pulmonary Arterial HypertensionWeak signal | None on record | — | — | — | — |
Nature Cell Co., Ltd.007390 · KOSDAQ | 1 asset: 1 Ph 2 | AstroStemPhase 2 · Alzheimer's DiseasePartial signal | None on record | — | — | — | — |
Oscotec Inc.039200 · KOSDAQ | 1 asset: 1 Ph 1 | OCT-598Phase 1 · Non-Small Cell Lung Cancer | Dec 2027OCT-598 · Phase 1 | — | — | — | — |
Parataxis Korea, Inc.288330 · KOSDAQ | 1 asset: 1 Ph 2 | BBT-207Phase 1/2 · Non-Small Cell Lung Cancer | None on record | — | — | — | — |
Peptron087010 · KOSDAQ | 1 asset: 1 Ph 2 | Exenatide (PT320)Phase 2 · Parkinson's DiseasePartial signal | None on record | — | — | — | — |
S.Biomedics304360 · KOSDAQ | 2 assets: 2 Ph 2 | Adipose-derived MSC clusters (S.Biomedics)Phase 1/2 · Atherosclerotic Cardiovascular DiseaseWeak signal | 7 Feb 2029TED-A9 (A9-DPC) · Phase na | — | — | — | — |
Sam Chun Dang Pharm. Co., Ltd.000250 · KOSDAQ | 1 asset: 1 other | Aflibercept (Vgenfli)Age-Related Macular Degeneration | None on record | — | — | — | — |
SCM Lifescience298060 · KOSDAQ | 1 asset: 1 Ph 2 | SCM-AGHPhase 1/2 · Atopic DermatitisPartial signal | None on record | — | — | — | — |
Shaperon378800 · KOSDAQ | 1 asset: 1 Ph 2 | HY209gelPhase 2 · Atopic DermatitisPartial signal | None on record | — | — | — | — |
SillaJen, Inc.215600 · KOSDAQ | 1 asset: 1 Ph 1 | BAL0891Phase 1 · Acute Myeloid Leukemia | 24 Dec 2026BAL0891 · Phase 1 | — | $3.7MDec 2025 | — | $11M |
STCube, Inc.052020 · KOSDAQ | 1 asset: 1 Ph 2 | NelmastobartPhase 2 · Non-Small Cell Lung Cancer | 31 Aug 2027Nelmastobart · Phase 2 | — | — | — | — |
Voronoi, Inc310210 · KOSDAQ | 2 assets: 2 Ph 2 | EnozertinibPhase 1/2 · Non-Small Cell Lung Cancer | Dec 2026Enozertinib · Phase 1 | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.